Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells
Graduate School of Biomedical Sciences; Whitehead Institute for Biomedical Research; Department of Cell Biology
Life Sciences | Medicine and Health Sciences
Pluripotency can be induced in differentiated murine and human cells by retroviral transduction of Oct4, Sox2, Klf4, and c-Myc. We have devised a reprogramming strategy in which these four transcription factors are expressed from doxycycline (dox)-inducible lentiviral vectors. Using these inducible constructs, we derived induced pluripotent stem (iPS) cells from mouse embryonic fibroblasts (MEFs) and found that transgene silencing is a prerequisite for normal cell differentiation. We have analyzed the timing of known pluripotency marker activation during mouse iPS cell derivation and observed that alkaline phosphatase (AP) was activated first, followed by stage-specific embryonic antigen 1 (SSEA1). Expression of Nanog and the endogenous Oct4 gene, marking fully reprogrammed cells, was only observed late in the process. Importantly, the virally transduced cDNAs needed to be expressed for at least 12 days in order to generate iPS cells. Our results are a step toward understanding some of the molecular events governing epigenetic reprogramming.
DOI of Published Version
Cell Stem Cell. 2008 Feb 7;2(2):151-9. Link to article on publisher's site
Cell stem cell
Brambrink T, Foreman RK, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R. (2008). Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. GSBS Student Publications. https://doi.org/10.1016/j.stem.2008.01.004. Retrieved from https://escholarship.umassmed.edu/gsbs_sp/1472